INTRODUCTION
Hexokinase has recently been added to the growing list of glycolytic enzymes which have been found to have abnormal activity in the red cells of certain patients suffering from congenital nonspherocytic hemolytic anemia. Since hexokinase, as the first step in the glycolytic chain, has a putative role in the -control of glycolytic rate in the red cell, an anomalous hexokinase is of interest to hematologist and biochemist alike. Valentine and his associates (1) have reported convincing evidence for hexokinase deficiency in the red These studies were initiated at the Thorndike Memorial Laboratory, Boston City Hospital, Boston, Mass. 02118, continued at the Naval Blood Research Laboratory, Chelsea, Mass. 02150, and concluded at the University of Florida College of Medicine, Gainesville, Fla. 32601. A preliminary report of this work has been published in abstract form (7) .
Received for publication 30 January 1969 and in retised form 16 May 1969. cells of a young girl with moderately severe chronic anemia. Although hexokinase activity was only slightly below the range of normal, a comparison between the activity of red cell hexokinase in the affected proposita and that in patients with diverse hemolytic anemias with comparably young cell populations greatly amplified the deficiency. The other members of the family had measured hexokinase activity which was similar to that of the patient except for one sibling with very low activity. None of these individuals had evidence of increased hemolysis.
This apparent lack of correlation between enzyme activity in broken cell systems and clinical severity has been a frequent finding among kindreds with congenital nonspherocytic hemolytic anemias associated with defective glycolytic enzymes. In addition to differences in mean cell age, several other factors may account for this phenomenon (2) . Such mutant enzymes may be unduly labile and activity may be lost during preparation for assay even though the function of the enzyme may be adequate in the intact cell. Conversely, normal or increased activity may be obtained in the conventional assay procedure but because of kinetic abnormalities of an anomalous enzyme, there is a marked functional blockade in the intact cell with resultant hemolytic anemia (3, 4) . It is probable that the majority of structural variants of catalytic proteins are not critically impaired either in activity or molecular stability and are clinically innocuous. Additional markers may be required to detect and define these complex disorders.
In all instances in which they have been properly measured, the glycolytic intermediates proximal and distal to an abnormal glycolytic enzyme associated with hemolytic anemia have shown marked deviations from normal (5) . These abnormalities may persist despite apparent fluctuations in the activity of the enzyme on conventional assay (6) and serve as a useful criterion for the presence of a significant block along the main pathway of anaerobic glycolysis. Careful measurement of the glycolytic intermediates on freshly drawn and immediately deproteinized blood probably represents the best available information on the functional state of the glycolytic The Journal of Clinical Investigation Volume 48 1969 chain in the circulating red cell, and avoids many potential artifacts inherent in enzyme assay, purification, and electrophoresis.
This report concerns the second kindred with imnpaired red cell hexokinase atcivity and hemolytic anemia. In addition to demonstrating abnormalities in the glycolytic intermediates of anemic as well as hematologically normal family members, the glycolytic rate in intact cells and its dependence on glucose concentration has been studied in a controlled incubation system which is described in detail. These studies suggest that this kindred possesses an abnormal red cell hexokinase which is unduly labile in the absence of glucose. Some of these studies have been published previously in preliminary form (7) .
Case report. The proposita is a 38 yr old psychiatric nurse who has been intermittently jaundiced and mildly anemic since childhood. At the age of 20, during nurse's training, she was hospitalized with presumptive hepatitis. At that time, her hematocrit was 38%, reticulocyte count 1.8%, total bilirubin 2.4 mg/100 ml, and a gallbladder X-ray was normal. She 
METHODS
Enzyme assays. The hexokinase assay described by Valentine et al. (1) is not optimal for the abnormal hexokinase of the proposita. Preparation of hemolysates and freezethawing in the absence of glucose cause incremental losses of activity and induce kinetic abnormalities such that the adenosine triphosphate (ATP) concentration is partially limiting. Therefore, a modification of the system described by Chapman et al. (8) was used for most assays. Cells were prepared for assay by repeated centrifugation in saline containing phosphate buffer (5 mmoles/liter) and glucose (5 mmoles/liter) at pH 7.4. Removal of the upper 5-10% of cells was essential since white cell contamination, particularly in deficient blood, is a major problem. After samples had been taken for red cell count (Coulter counter) and white However, the given rates have not been corrected for this. White cell hexokinase activity was measured in the same assay system. White cells were prepared from whole blood, and were frozen and thawed three times with methanol-dry ice and the stroma was removed by spinning at 30,000 g for 20 min. The red cell contamination was less than 20%7o and was considered negligible because of the very high white cell hexokinase activity relative to that in the red cells. The preparation consisted of over 90% granulocytes. The following enzyme activities were measured in hemolysates from the red cells of the proposita according to the cited methods with minor modifications: glucose 6-phosphate dehydrogenase (G6PD) (9), aldolase (10), glyceraldehyde 3-phosphate dehydrogenase (G3PD) (11), (forward and backward assay) triose phosphate isomerase (TPI) (12) , phosphoglycerate kinase (PGK) (backward assay) (11) , and pyruvate kinase (PK) (13) . With the exception of PK and TPI (values given in the text) no attempt was made to establish a normal range. Rather, the activity in hemolysates from the patient's cells was compared with that from identically prepared hemolysates from the red cells of a normal control subj ect. In all cases appropriate blanks were performed and assay activity was verified with commercial enzymes of stated purity (Calbiochem or BoehringerMannheim).
Measurement of glycolytic intermediates. Whole blood was drawn in a heparinized syringe and an aliquot was immediately (within 10-20 sec) deproteinized in two volumes of cold 6% (w/v) perchloric acid (PCA). After at least 15 min on ice, extracts were spun at 12,000 g for 10 min and the clear supernatant removed. The samples were neutralized (pH 6.5-7.0) with potassium bicarbonate (approximately 130 ,l of a 2 M solution per ml of extract). Assays for glucose, glucose 6-phosphate (G6P), 3- Hemolytic Anemia with Impaired Hexokinase Activity 1999 a potentiometric recorder. Two cylinders, one of compressed air and one of 10% C02 in air supply the gas phase. The 1070 CO2 in air stream is routed through thin-walled rubber tubing to an on-off magnetic valve 10 which is controlled by an automatic titrator.'3 After passage through flow meters, the gas is mixed under water in a small tube and delivered to the incubation flask by catheter (the aspirator tube from a package of disposable Sahli pipets of Clay-Adams is convenient). Customarily, a constant flow of air is delivered at about 50 cc/min and, upon demand, the 10% CO2 in air is added at 150 cc/min making an approximate 7.5% CO-air mixture. If the pH is to be varied, it can be done quickly by immersing the delivery catheter in the cell suspension and bubbling briefly at low gas flow without causing appreciable hemolysis or affecting steady-state conditions. This system, after equilibration, maintains constant pH in dilute red cell suspensions within +0.01 U of the end point setting. To forestall problems of protein poisoning of the glass electrode membrane, two electrodes may be used alternately (with restandardization) although most studies were sufficiently short that only one was necessary. Several of the water-jacketed flasks are arranged in series to a high capacity circulating pump' on a four-place magnetic stirring plate.'3 The extra vessels serve to pre-equilibrate and standardize the pH electrode at 370C in a standard buffer and to bring any additives to the same temperature.
In most studies, either 20 or 40 ml of dilute cell suspension (hematocrit 10-20%) were incubated in 25-or 50-ml siliconized spinner flasks respectively at pH 7.40 ±0.01. Because of the large volume of the incubate relative to the sample size, (500 or 1000 il) and the relatively slow equilibration time, it is possible to remove frequent samples without altering the pH. Samples are removed through a sidearm port after a few seconds of vigorous stirring with 500 or 1000 /Al constriction pipets 14 and delivered into 0.5, 1.0, or 2.0 volumes of cold PCA depending on the hematocrit. Subsequently, the samples are handled and analyzed as described above. All of the measured compounds appear to be stable after neutralization, on storage at -20'C except pyruvate (see Lowry et al. [14] ) which was measured immediately after it was neutralized.
By adjusting the hematocrit and initial glucose concentration, any desired rate of glucose disappearance may be obtained. To obtain slopes which can be accurately measured in reasonably short incubation periods, the initial glucose concentration must be quite low and an accurate and sensitive assay is required. The extreme sensitivity and linearity of the fluorometric glucose assays over the range of tube concentrations employed in the assays is demonstrated in Fig. 1 . This system has several advantages over other methods which can measure glucose consumption at very low levels by assaying the radioactive products which appear during incubation with "4C-labeled glucose. It is possible to sample repetitively from the same vessel without terminating the incubation for each experimental point to collect labeled C02. By analyzing many points, both the linearity and the rate of glucose disappearance may be determined and possible artefacts due to failure to achieve steady-state conditions may be more readily detected. Table II , the levels of various glycolytic intermediates in the freshly drawn red cells of this kindred are compared with those from 10 hematologically normal donors. A consistently low value for G6P is apparent in all members which is most marked in the two anemic patients, and was reproduced many times in the proposita.
The ATP level was slightly below normal in both patients with overt hemolysis while the ADP level was slightly increased only in the proposita. The level of 2,3-DPG was consistently low in the proposita and was lower than all but one normal blood in her sister. A decreased level of 2,3-DPG has previously been found only in patients with presumed deficiency of 2,3-DPG mutase (17, 18) and in certain Dutch patients with high ATP levels (19) . The latter patients had slightly elevated hemoglobin values, suggesting that their concentration of 2,3-DPG was not adequate for proper hemoglobin-oxygen equilibrium. The nearly complete degree of compensation of the anemia in the proposita may also be related to her low concentrations of 2,3-DPG and ATP (20) . The normal values, as shown in Table II Fig. 2 a. When glucose, mercaptoethanol, and EDTA were present in the hemolyzing solution, the repeat assay values were uniformly higher and the distinction between anemic, nonanemic, and normal individuals became much less clear. The abnormal ATP requirement for the hexokinase from the proposita disappeared under these conditions as shown in Fig. 2 b. The reason for the loss of activity in the hemolysates prepared without glucose was explored in the proposita. As shown in Table IV , hexokinase activity is unstable during storage at 2°C in aqueous hemolysates, an effect which is apparent immediately in the abnormal hemolysate, but only after 5-21 days in hemolysates from cells of normal individuals. This deterioration is delayed by adding EDTA and 2-mercaptoethanol to the hemolyzing solution and is abolished when glucose is also present. No significant difference in hexokinase activity in normal fresh hemolysates with and without glucose could be found, whereas the presence of glucose, mercaptoethanol, and EDTA resulted in consistently higher activity in fresh hemolysates from the proposita. That glucose also stabilized normal red cell hexokinase can be demonstrated by mild heating to 45°C. Glucose, mercaptoethanol, and EDTA, and to a lesser extent 2-mercaptoethanol and EDTA alone, protect normal hexokinase activity for a least 30 min at this temperature, whereas activity is rapidly lost in simple distilled water hemolysates (Table IV) . Glucose alone will fully protect the activity of normal hexokinase under these conditions (not shown).
Assays of white cell hexokinase were performed in the same assay system but at 37°C and are shown in Table V . The white cells from the proposita had normal activity when compared with three normal controls. The ratio of white cell activity to red cell activity (also assayed at 37°C) is very high on a per cell basis, approximating 300 to 1 in normal blood. Therefore a 3000-fold excess of red cells over whites would be required to achieve less than 10% contaminating white cell activity in the red cell assay. This may be particularly difficult to achieve in postsplenectomy patients with elevated reticulocyte and white cell counts, and the removal of white cells by aspiration of the top layer of cells will remove variable numbers of reticulocytes.
Electrophoresis ' of both white cell and red cell preparations on agarose medium at pH 7 The activities of G6PD, aldolase, and G3PD were greater than the activities of control hemolysate. PGK activity was 82% of the control value. However, a significant deficiency of this enzyme in the patient's intact cells is considered very unlikely because of their low concentration of 2,3-DPG. In the only well documented cases of deficiency of PGK, 2,3-DPG was approximately twice normal (24) .
Glucose consumption in intact cells. The disappearance of glucose from suspensions of normal red cells and red cells from the proposita was followed in the previously described incubation system. When normal cells (Fig. 3) reach a glucose concentration below approximately 0.05 mmole/liter, they display a characteristic pattern in which G6P falls abruptly and pyruvate begins to accumulate. If sufficiently frequent samples are analyzed, a simultaneous drop in the rate of glucose consumption and lactate production is apparent but in most experiments with normal cells this slight deviation from linearity could not be detected before glucose disappeared completely. ATP, ADP, and TTP levels are stable until after glucose disappears. Under these conditions, the fall in G6P, which precedes glucose exhaustion, serves as a marker for the point at which glucose concentration begins to limit the hexokinase reaction. When cells from the proposita are similarly incubated (Fig. 4) , G6P drops to very low levels and there is abnormal accumulation of pyruvate throughout the incubation. Glucose consumption is linear only to about 0.2 mmoles/liter and then lags, showing a consistent "tail." The rate of pyruvate accumulation increases sharply at this time and lactate production decreases. Maintaining a true steady state in vitro proved very difficult in these cells and ATP and 2,3-DPG decreased slowely throughout the period of incubation in most experiments. It is therefore impossible to establish a priori whether glucose concentration or ATP concentration becomes limiting for the hexokinase reaction as the glycolytic rate slows. To resolve this question, glucose was restored to the cells after it had been completely exhausted and the ATP level had fallen to less than 50% of its initial level (Fig. 5) . Glucose consumption resumed at a rate similar to the initial rate indicating that glucose rather than ATP concentration was the likely factor responsible for the "tail" on the disappearance curve.
To examine the possibility that the very low G6P level present throughout the incubation of the patient's cells might influence the shape of the glucose disappearance curve, incubations were performed with normal red cells under conditions inducing a drop in G6P level. As shown in Fig. 6 , normal linear disappearance was noted in the presence of methylene blue (6 a), despite the lowering of G6P level induced by this -glycolytic stimulant. Similarly, the red cells of a patient with hereditary elliptocytosis, with a reticulocyte count of 12% (similar to that of the proposita) maintained a constant rate of glucose utilization without measurable slowing at low concentrations of glucose (Fig. 6 b) . The steady-state level of G6P in these cells was increased in contrast to the abnormal cells.
Because of the difficulty in achieving steady-state conditions during incubation of the cells from the patient, the absolute glycolytic rate is somewhat uncertain. Using the linear portion of the curve or initial rates, the consumption ranged from 1.3 to 1.6 (/Amoles/ml of cells per hr) compared with a normal steady-state rate of 1.6-1.8. This slight under-utilization of glucose is amplified by comparison with the elliptocytic cells of roughly comparable age which utilized glucose at 3.67 /Amoles/ml of cells per hr. ates is complex and they should be considered a necessary but not sufficient criterion for the presence of an enzymatic lesion in the glycolytic chain. The required 0.2 assumption is that a significant discrete lesion in the glycolytic pathway will show a "crossover" point (25) Utter (26) . Hexokinase is a particularly difficult point at which to apply "crossover" reasoning for several reasons. The first is that intracellular glucose conlcentration, because of the extremely high capacity of the glucose transport system in the red cell membrane, reflects alterations in blood glucose rather than changes in hexokinase activity. Therefore accumulation of the substrate of the reaction cannot be demonstrated. Secondly, the concentration of G6P is controlled not only by hexokinase but also by G6PD and PFK, and a secondary stimulation of these enzymes can lower the G6P levels. The normal to low concentration of the more distal intermediates is useful evidence against the presence of a defective glycolytic enzyme other than hexokinase but does not exclude hemolysis from other causes. It should be emphasized that the levels of G6P and TTP are subject to very rapid change after blood is drawn. Therefore a neutral anticoagulant and immediate deproteinization are mandatory. White cell and platelet contribution to the levels of glycolytic intermediates is negligible and attempts to remove them will preclude any consistent results with these intermediates.
It is quite possible that G6PD and PFK are stimulated in the cells of the proposita. Normal cells respond to the resultant drop in G6P concentration with increased glucose consumption because G6P, by inhibiting hexokinase, exerts a major regulatory role in the control of glycolytic rate (27) . Therefore the failure of the abnormal cells to demonstrate an increased glycolytic rate appropriate to the low G6P concentration indicates deficient hexokinase activity regardless of the state of G6PD or PFK. Hexokinase is also inhibited by a fall in the ATP/ADP ratio. However, in the experiment depicted in Fig. 5 , a fall from 4.5 to 1.1 in the ATP/ADP ratio did not further limit glycolytic rate when glucose was restored to the medium. Furthermore, G6P concentration was also decreased in the family members who had normal ATP/ADP ratios.
Accumulation of pyruvate is a sensitive indicator of a slowing of the initial glycolytic reactions. hexokinase can be demonstrated by mild heating of hemolysates prepared in the absence of glucose, which is abolished if glucose is restored at any time before heating. This behavior is characteristic of the type II isoenzyme of hexokinase from other tissues (28), although the major component of red cell hexokinase has the electrophoretic mobility of the type I isoenzyme (29) (30) (31) . These findings make it unlikely that the protective effect of glucose in hemolysates is mediated by reduced gluthathione, since this compound cannot be regenerated with glucose in unfortified hemolysates. Rather, the stabilization by substrate and partial protection afforded by the sulfhydryl compound mercaptoethanol suggest that a change in tertiary or quaternary structure is induced by substrate binding which renders the protein less favorable for oxidative attack at its reactive sulfhydryl group. Protection of enzyme activity against thermal, oxidative, or proteolytic denaturation by substrate binding or in the presence of an allosteric modifier has been demonstrated for many enzymes including hexokinase (28, 32) . The possible significance of this lability in intact cells in vivo where the cells are saturated with glucose and reduced gluthathione is at normal levels is uncertain. The enzyme is not apparently rapidly denatured in intact cells of the proposita when they were washed free of glucose since full activity was retained if the cells were subsequently hemolyzed with glucose mercaptoethanol and EDTA. However, the poor performance of the cells during incubation, with failure to maintain the levels of ATP, 2,3-DPG, and G6P found in vivo, indicates that hexokinase function may have been altered by the manipulations even though glucose was constantly present.
The possibility has been considered that the (lemonstrable impairment of hexokinase activity in this patient's intact cells and its lability in hemolysates may reflect some abnormal oxidative stress. Hexokinase from several mammalian tissues, including human erythrocytes, are inhibited in the presence of certain disulfides and this inhibition is considerably relieved by the presence of glucose (32) . It has been shown that in the presence of certain unstable hemoglobins, mixed disulfide formation occurs between reduced gluthathione and the reactive sulfhydryl groups of the f-chains of hemoglobin (33) . In the subsequent unfolding and precipitation of these hemoglobins, additional reactive SH groups are exposed which form disulfide linkages with membrane (34) and presumably might also affect the activity and stability of SH enzymes such as hexokinase. Metabolic studies of red cells containing unstable hemoglobins have shown a stimulation of the HMP shunt and marked lability of ATP (35, 36) . However, in both Koln and Sabine hemoglobinopathies the glycolytic rate of red cells incubated in vitro was significantly increased, indicating that hexokinase was not significantly affected. The decreased glycolysis, the absence of Heinz bodies in the circulating red cells after splenectomy, and the normal level of reduced gluthathione provide evidence against the presence of an unstable hemoglobin variant in this case.
